Top Stock Reports for Chevron, AstraZeneca & Arista Networks
阿斯利康(AZN.US)1类新药首次在中国获批临床 拟开发治疗心力衰竭
AstraZeneca Partner's Orpathys Secures Renewal on China's Drug Reimbursement List
AstraZeneca's Breast Cancer Drug Wins State Insurance Coverage in China
Failure of AstraZeneca's AZD4041 a Blow for Non-opioid OUD Treatments
安进(AMGN.US)发布减肥疗法MariTide中期数据 减重效果不输诺礼
阿斯利康(AZN.US)联合疗法Truqap组合3期试验结果积极
阿斯利康Capivasertib前列腺癌III期成功 来凯医药-B(2105.HK)AKT抑制剂前景看好
AstraZeneca Reports Positive Phase 3 Results for Truqap in Prostate Cancer
TRUQAP (Capivasertib) Combination in PTEN-deficient Metastatic Hormone-sensitive Prostate Cancer Demonstrated Statistically Significant and Clinically Meaningful Improvement in Radiographic Progression-free Survival in CAPItello-281 Phase III Trial
GCAR and AstraZeneca Execute Agreement to Evaluate AZD1390 for Glioblastoma
AstraZeneca's Prostate Cancer Treatment Trial Shows Clinically Meaningful Improvement
AstraZeneca (AZN): A Top Pick for Hedge Funds Due to Innovation and Rising Demand
Pfizer Meets Amyloidosis Rival as BridgeBio Wins FDA Nod for Attruby
Trump Picks Surgeon Makary to Head FDA, Rep. Dave Weldon to Lead CDC
European Equities Traded in the US as American Depositary Rise in Friday Trading, Up Over 1% for Week
阿斯利康(AZN.US)、安进(AMGN.US)皮下注射TSLP 单抗国内报上市
Amneal Gets FDA Approval for Generic Byetta, Resubmits DHE NDA
Optimism Over Global Healthcare Sector Rises: Jefferies
AstraZeneca's Andexxa Faces FDA Scrutiny Over Effectiveness, Safety Concerns